Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oncogene|April 15, 2005
Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptorsMark B Klinger, Benoit Guilbault, Rebecca E Goulding, et al.
Clinical Endocrinology|March 1, 1992
IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-IZ Laron, B Klinger, W F Blum, et al.
Metabolism: Clinical and Experimental|October 1, 1996
Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndromeZ Laron, X L Wang, B Klinger, et al.
Clinical Endocrinology|November 1, 1995
Intranasal administration of the GHRP hexarelin accelerates growth in short childrenZ Laron, J Frenkel, R Deghenghi, et al.
European Journal of Endocrinology|April 1, 1997
Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)Z Laron, X L Wang, B Klinger, et al.
Israel Journal of Medical Sciences|December 1, 1993
Laron syndrome due to a post-receptor defect: response to IGF-I treatmentZ Laron, B Klinger, R Eshet, et al.
Acta Endocrinologica|September 1, 1990
Intravenous administration of recombinant IGF-I lowers serum GHRH and TSHZ Laron, B Klinger, A Silbergeld, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1994
Serum growth hormone-binding protein (GHBP) activity is decreased by administration of insulin-like growth factor I in three Laron syndrome siblings with normal GHBPA Silbergeld, B Klinger, R Keret, et al.
Pageof 6